CL vs REGN · P/E 34, rev $20.38B vs P/E 14, rev $14.34B
Colgate-Palmolive Company (CL) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Colgate-Palmolive Company (CL) is a household & personal products company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported CL revenue for 2025-12-31 was $20.38B. Net income was $2.13B. Revenue was up 1.4% from 2024-12-31 to 2025-12-31. CL currently screens at market cap $70.88B and trailing P/E 34.3.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
CL currently screens at market cap $70.88B and trailing P/E 34.3. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the CL and REGN stock pages for the full models.
Not investment advice.